Literature DB >> 19451015

Evaluation of gastric emptying in familial and sporadic Parkinson disease.

Anna Krygowska-Wajs1, William P Cheshire, Zbigniew K Wszolek, Alicja Hubalewska-Dydejczyk, Barbara Jasinska-Myga, Matthew J Farrer, Marek Moskala, Anna Sowa-Staszczak.   

Abstract

OBJECTIVE: To assess for the presence of gastric dysmotility in familial and sporadic Parkinson disease (PD).
METHODS: 10 subjects with familial Parkinson disease (fPD), 35 subjects with sporadic Parkinson disease (sPD), and 15 controls, all from academic tertiary care movement disorders centers, were studied. fPD was defined as the presence of at least 2 affected individuals within 2-3 consecutive generations in a family. Molecular genetic analysis has not revealed, thus far, any known genomic abnormality in these families. Gastric emptying was assessed by dynamic abdominal scintigraphy over 92 min following ingestion of a solid meal containing 99mTc-labeled colloid of 40 MBq activity. The main outcome measures were gastric emptying half-time and radiotracer activity over the gastric area at 46 and at 92 min.
RESULTS: Gastric emptying time was delayed in 60% of subjects with PD. In comparison to mean t(1/2) of 38 +/- 7 min in controls, mean t(1/2) was 58 +/- 25 min in fPD (p = 0.02) and 46 +/- 25 min in sPD (p = 0.10). Both fPD and sPD groups included subjects with delayed gastric emptying at an early stage of disease.
CONCLUSIONS: Patients with fPD showed significantly delayed gastric emptying in comparison to normal age-matched individuals. Further studies of gastrointestinal dysfunction in PD, particularly fPD, are warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19451015      PMCID: PMC3905598          DOI: 10.1016/j.parkreldis.2009.04.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  29 in total

1.  Sympathetic neurocirculatory failure in Parkinson disease: Evidence for an etiologic role of alpha-synuclein.

Authors:  D S Goldstein; S T Li; I J Kopin
Journal:  Ann Intern Med       Date:  2001-12-04       Impact factor: 25.391

2.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

3.  Cardiac sympathetic denervation in Parkinson disease.

Authors:  D S Goldstein; C Holmes; S T Li; S Bruce; L V Metman; R O Cannon
Journal:  Ann Intern Med       Date:  2000-09-05       Impact factor: 25.391

4.  Frequency of bowel movements and the future risk of Parkinson's disease.

Authors:  R D Abbott; H Petrovitch; L R White; K H Masaki; C M Tanner; J D Curb; A Grandinetti; P L Blanchette; J S Popper; G W Ross
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

5.  Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey.

Authors:  M F Siddiqui; S Rast; M J Lynn; A P Auchus; R F Pfeiffer
Journal:  Parkinsonism Relat Disord       Date:  2002-03       Impact factor: 4.891

6.  Gastric electromechanical dysfunction in Parkinson's disease.

Authors:  A Krygowska-Wajs; K Lorens; P Thor; A Szczudlik; S Konturek
Journal:  Funct Neurol       Date:  2000 Jan-Mar

Review 7.  Gastrointestinal dysfunction in Parkinson's disease.

Authors:  Ronald F Pfeiffer
Journal:  Lancet Neurol       Date:  2003-02       Impact factor: 44.182

8.  Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication.

Authors:  Amanda Singleton; Katrina Gwinn-Hardy; Yehonotan Sharabi; Sheng-Ting Li; Courtney Holmes; Raghuveer Dendi; John Hardy; Andrew Singleton; Anthony Crawley; David S Goldstein
Journal:  Brain       Date:  2004-01-21       Impact factor: 13.501

9.  Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies.

Authors:  Horacio Kaufmann; Kirsty Nahm; Dushyant Purohit; David Wolfe
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

10.  Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system.

Authors:  K Wakabayashi; H Takahashi; E Ohama; F Ikuta
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

View more
  7 in total

Review 1.  Imaging the Autonomic Nervous System in Parkinson's Disease.

Authors:  Karoline Knudsen; Per Borghammer
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-19       Impact factor: 5.081

2.  "New methods of assessing autonomic disorders in Parkinson disease patients: skin-galvanic reaction".

Authors:  Justyna Dutkiewicz; Stanisław Szlufik; Andrzej Friedman
Journal:  J Neural Transm (Vienna)       Date:  2019-09-28       Impact factor: 3.575

Review 3.  Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's disease.

Authors:  Richard A Awad
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

Review 4.  Imaging Systemic Dysfunction in Parkinson's Disease.

Authors:  Per Borghammer; Karoline Knudsen; David J Brooks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

5.  Imaging Parkinson's disease below the neck.

Authors:  Per Borghammer; Karoline Knudsen; Tatyana D Fedorova; David J Brooks
Journal:  NPJ Parkinsons Dis       Date:  2017-04-25

6.  Gastric Emptying Is Not Delayed and Does Not Correlate With Attenuated Postprandial Blood Flow Increase in Medicated Patients With Early Parkinson's Disease.

Authors:  Thomas Hartwig Siebner; Stefan Fuglsang; Christopher Fugl Madelung; Annemette Løkkegaard; Flemming Bendtsen; Jens Dahlgaard Hove; Morten Damgaard; Jan Lysgård Madsen; Hartwig Roman Siebner
Journal:  Front Neurol       Date:  2022-02-24       Impact factor: 4.003

7.  Small intestine dysfunction in Parkinson's disease.

Authors:  Justyna Dutkiewicz; Stanisław Szlufik; Michał Nieciecki; Ingeborga Charzyńska; Leszek Królicki; Piotr Smektała; Andrzej Friedman
Journal:  J Neural Transm (Vienna)       Date:  2015-08-26       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.